T1	Participants 92 180	Twenty-six postmenopausal women participated in a double-blind trial involving treatment
T2	Participants 624 643	combination therapy
T3	Participants 871 890	combination therapy
T4	Participants 944 952	placebo.
T5	Participants 708 716	control.
T6	Participants 990 1009	combination therapy
T7	Participants 1569 1589	combination therapy.
T8	Participants 1407 1414	control
